Instylla announces positive results from preclinical studies of Embrace™ Hydrogel Embolic System in hemorrhage models
BEDFORD, Mass., July 26, 2022 /PRNewswire/ — Instylla, Inc., a privately held company developing next-generation liquid embolics for…